Effects of early, late and self-selected time-restricted eating on visceral adipose tissue and cardiometabolic health in participants with overweight or obesity: a randomized controlled trial.
СтатьяМногоцентровое исследованиеРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dote-Montero Manuel, Clavero-Jimeno Antonio, Merchán-Ramírez Elisa, Oses Maddi, Echarte Jon, Camacho-Cardenosa Alba, Concepción Mara, Amaro-Gahete Francisco J, Alcántara Juan M A, López-Vázquez Alejandro, Cupeiro Rocío, Migueles Jairo H, De-la-O Alejandro, García Pérez Patricia V, Contreras-Bolivar Victoria, Muñoz-Garach Araceli, Zugasti Ana, Petrina Estrella, Alvarez de Eulate Natalia, Goñi Elena, Armendariz-Brugos Cristina, González Cejudo Maria T, Martín-Rodríguez Jose L, Idoate Fernando, Cabeza Rafael, Carneiro-Barrera Almudena, de Cabo Rafael, Muñoz-Torres Manuel, Labayen Idoia, Ruiz Jonatan R
Аннотация
The optimal eating window for time-restricted eating (TRE) remains unclear, particularly its impact on visceral adipose tissue (VAT), which is associated with cardiometabolic morbidity and mortality. We investigated the effects of three TRE schedules (8 h windows in the early day, late day and participant-chosen times) combined with usual care (UC, based on education about the Mediterranean diet) versus UC alone over 12 weeks in adults with overweight or obesity. The primary outcome was VAT changes measured by magnetic resonance imaging. A total of 197 participants were randomized to UC (n = 49), early TRE (n = 49), late TRE (n = 52) or self-selected TRE (n = 47). No significant differences were found in VAT changes between early TRE (mean difference (MD): -4%; 95% confidence interval (CI), -12 to 4; P = 0.87), late TRE (MD: -6%; 95% CI, -13 to 2; P = 0.31) and self-selected TRE (MD: -3%; 95% CI, -11 to 5; P ≥ 0.99) compared with UC, nor among the TRE groups (all P ≥ 0.99). No serious adverse events occurred; five participants reported mild adverse events. Adherence was high (85-88%) across TRE groups. These findings suggest that adding TRE, irrespective of eating window timing, offers no additional benefit over a Mediterranean diet alone in reducing VAT. TRE appears to be a safe, well-tolerated and feasible dietary approach for adults with overweight or obesity. ClinicalTrials.gov registration: NCT05310721 .